Imagen de Portada

Central Adiposity and Visceral Fat in Long‐Term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: Exploration of an Underappreciated Risk

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Louise Guolla, Ashlyn Chou, Troy H. Farncombe, Lehana Thabane, Katherine Morrison, Ronald D. Barr
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Pediatric Blood & Cancer
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Visceral Fat and Body Fat as Risk Factors for Methotrexate Toxicity in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
por: Alda Daniela García‐Guzmán, et al.
Publicado: (2025)

Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of Instruments
por: Jammbe Musoro, et al.
Publicado: (2024)

Risk of Metabolic Syndrome and Glucose Homeostasis Among Childhood and Young Adult Acute Lymphoblastic Leukemia Survivors: Part of the ALL‐STAR Study
por: Mette Tiedemann Skipper, et al.
Publicado: (2025)

Blinatumomab‐Associated Psychosis in an Adolescent With B‐Cell Acute Lymphoblastic Leukemia
por: Eesha A. Zaheer, et al.
Publicado: (2026)

Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial
por: Nirali N. Shah, et al.
Publicado: (2025)

Social Participation Among Long‐Term Survivors of Childhood and Adolescent Cancer
por: Clarissa E. Schilstra, et al.
Publicado: (2025)

Comparing Parent and Child Reports of School Functioning as Predictors of Neurocognitive Test Performance in Hispanic/Latino Survivors of Childhood Leukemia/Lymphoblastic Lymphoma
por: Melissa Balderrama, et al.
Publicado: (2026)

Longitudinal Patterns of Fatigue in Long‐Term Survivors of Childhood and Adolescent Cancers: A Report From the Swiss Childhood Cancer Survivor Study
por: Salome Christen, et al.
Publicado: (2025)

Cytarabine‐Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia
por: Ashley C. Holland, et al.
Publicado: (2025)

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
por: Andrew E. Place, et al.
Publicado: (2025)

Successful Caribbean Cooperation in Childhood Cancer Care: The Martinique—St. Lucia–Dominica Experience in the Management of Acute Lymphoblastic Leukemia
por: Julie Mascle, et al.
Publicado: (2025)

BCG Infection Following Therapy of Infant Acute Lymphoblastic Leukemia
por: Mikhail Lemeshev, et al.
Publicado: (2026)

Monosomy 10 Mosaicism as an Incidental Finding in Acute Lymphoblastic Leukemia
por: Dany Assaf Curi, et al.
Publicado: (2025)

Temporal Relationships Between General Self‐Efficacy, Social Support and Health‐Related Quality of Life Among Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A 9‐Year Follow‐Up Study
por: Katarina Aili, et al.
Publicado: (2025)

Association Between Maternal Infection During Pregnancy and the Risk of Childhood Acute Lymphoblastic Leukemia in Offspring: A Systematic Review and Meta‐Analysis
por: Xi Chen, et al.
Publicado: (2026)

Successful Medical Management of Gastrointestinal Invasive Mucormycosis with Associated Bowel Perforation in an Adolescent Patient with pre‐B Cell Acute Lymphoblastic Leukemia
por: Heather Valdin, et al.
Publicado: (2025)

Research Progress of Metabolic Reprogramming in Childhood Acute Leukemia
por: Yuzhi Yan, et al.
Publicado: (2026)

Heterogeneity in the Global Practice of Central Nervous System Staging in Pediatric Acute Lymphoblastic Leukemia
por: Laura Almási, et al.
Publicado: (2026)

Disseminated Infection Following the Administration of the Varicella Vaccine in a Child with Acute Lymphoblastic Leukemia
por: Ryo Hanaki, et al.
Publicado: (2025)

Ongoing Worry, Information Needs, and Engagement in Care for Parents of Long‐Term Childhood Cancer Survivors
por: Katia M. Crisler, et al.
Publicado: (2025)

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West
por: Angela Parra del Riego, et al.
Publicado: (2026)

Use of Oral Metformin Therapy for Therapy‐Induced Hyperglycemia in Pediatric Patients With Acute Lymphoblastic Leukemia
por: Ankita Chakraborty, et al.
Publicado: (2026)

Reduced‐Intensity Chemotherapy With Immunotherapy for Children With Down Syndrome and B‐Cell Acute Lymphoblastic Leukemia
por: Ashley C. Holland, et al.
Publicado: (2025)

Venetoclax Plus Daratumumab Bridging Allo‐HSCT in Early T‐Cell Precursor Acute Lymphoblastic Leukemia
por: Fanqiao Meng, et al.
Publicado: (2025)

Attitudes Toward COVID‐19 Vaccination Among Pediatric Acute Lymphoblastic Leukemia Patients and Their Caregivers
por: Janna R. Shapiro, et al.
Publicado: (2025)

Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia
por: Kellee N. Parker, et al.
Publicado: (2026)

Caregiving for Children With Acute Lymphoblastic Leukemia Receiving Home‐Based Blinatumomab: Caregiver Experiences and Recommendations
por: Sue Zupanec, et al.
Publicado: (2025)

Late Onset Blinatumomab‐Related Neurotoxicity in a Child With B‐Cell Acute Lymphoblastic Leukemia
por: Krunal Shah, et al.
Publicado: (2025)

Impact of Invasive Fungal Diseases on Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Insights From a Single‐Center Study
por: Amrutha Narayana Murthy, et al.
Publicado: (2025)

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia
por: Janna R. Shapiro, et al.
Publicado: (2026)

Pediatric Acute B‐Lymphoblastic Leukemia Presenting as Hypereosinophilia With Lung Involvement and Elevated Immunoglobulin E Levels
por: Aida Zeckanovic, et al.
Publicado: (2024)

A Retrospective Study to Identify Demographic and Clinical Risk Factors for the Development of Methotrexate‐Associated Neurotoxicity in Children and Young Adults With Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
por: Cassandra Grello, et al.
Publicado: (2025)

Prolonged Hypogammaglobulinemia in a Child With Down Syndrome After Treatment of Acute Lymphoblastic Leukemia With Immunochemotherapy Including Blinatumomab
por: Reena Pabari, et al.
Publicado: (2025)

First‐Line Postremission Blinatumomab as Successful Toxicity‐Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia
por: Nicolò Peccatori, et al.
Publicado: (2025)

Results of a Randomized Augmented Intensification Phase in Acute Lymphoblastic Leukemia in Children in Argentina: GATLA 2010 ALL IC Trial
por: Maria C. Riccheri, et al.
Publicado: (2025)

Bridging the Gap in Pediatric Relapsed Acute Lymphoblastic Leukemia Treatment: Insights and Outcomes From the ALL‐IC REL 2016 Guidelines
por: Marko Kavcic, et al.
Publicado: (2025)

Changes in Body Composition in Children and Young People Undergoing Treatment for Acute Lymphoblastic Leukemia: A Systematic Review and Meta‐Analysis
por: Lina A. Zahed, et al.
Publicado: (2026)

Genomics of Long‐Term Complications of Childhood Leukemia: Rationale and Design of the GenLEA Study
por: Mathilde Veneziano‐Broccia, et al.
Publicado: (2026)

Management of Philadelphia Chromosome‐Positive B‐Lymphoblastic Leukemia Diagnosed in an Infant
por: Jessica A. O. Zimmerman, et al.
Publicado: (2025)

Sedation with Oral Dexmedetomidine Premedication in Pediatric Patients With Acute Lymphoblastic Leukemia Undergoing Blood Sampling: A Randomized, Double‐Blind Clinical Trial
por: Farshad Khoddami, et al.
Publicado: (2026)